Thursday May 25th 2017

Archive for October, 2010

Seattle women ‘liberate’ themselves from MS

Seattle women ‘liberate’ themselves from MS

The medical community is being turned upside down – because of a new treatment for multiple sclerosis. It’s called the “Liberation procedure” – but it’s almost impossible to get. So two local women with the disease decided to take [Read More]

Vancouver company cashes in on MS treatment

Vancouver company cashes in on MS treatment

A Vancouver-based medical tourism company is cashing in on the reluctance by many provincial governments to fund a controversial therapy to treat multiple sclerosis. Passport Medical has arranged for foreign treatment using so-called liberation therapy for more than 350 MS [Read More]

Informal fraternity links MS sufferers seeking liberation therapy

Informal fraternity links MS sufferers seeking liberation therapy

An informal fraternity is emerging among people seeking or who have already received a scientifically untested, but promising, foreign treatment for multiple sclerosis, a progressively debilitating brain and spinal cord disease. Guelph’s Mel Roumeliotis had liberation [Read More]

 Page 1 of 17  1  2  3  4  5 » ...  Last » 

Latest Topics

Study finds variations among hospitals in transitioning stroke patients from treatment to comfort care

Study finds variations among hospitals in transitioning stroke patients from treatment to comfort care

Hospitals vary widely in how often they transition people with strokes from active treatment to comfort or hospice care [Read More]

Roche investigating case of patient illness after taking MS drug

Roche investigating case of patient illness after taking MS drug

ZURICH (Reuters) - A person in Germany treated with Roche ’s new multiple sclerosis drug Ocrevus has been diagnosed [Read More]

MS Study Alert: Share Your Thoughts About MS Research

MS Study Alert: Share Your Thoughts About MS Research

/About-the-Society/News/MS-Study-Alert-Share-Your-Thoughts-About-MS-Resea [Read More]

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

UK-based specialist pharmaceutical firm Mallinckrodt has begun patient enrolment in the Phase IV OPTIONS clinical trial [Read More]

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

/About-the-Society/News/First-Results-Announced-from-Second-Phase-III-Tria [Read More]